Workshop CD30- Positive lymphoid malignancies will take place from the 6th to 8th of February in Santander. This is an educational activity, developed by the Pathology Service in the University Hospital Marques de Valdecilla and supported by a grant from TAKEDA. These workshops are designed to improve the diagnostic capacity of haematopathologists across the world, […]
Researchers belonging to the Valdecilla Hospital and the University of Cantabria, of the IDIVAL Group Cytokines and growth factors in pathological tissue plasticity phenomena have collaborated in a study published last Monday in the prestigious journal Nature Medicine in which it is shown that the pharmacological inhibition of The NOS2 protein not only prevents pathological dilatation […]
The fourth session of the Programme Valdecilla Progress Reports will take place on the 18th of January. The conference will be given by Beatriz Abascal Bolado, Pneumology Specialist at the University Hospital Marqués de Valdecilla, post-MIR contract Wenceslao López Albo with a stay at the Mayo Clinic, in Rochester, Minnesota. The session will be […]
Progress Reports´ seminars began in October 2016 with the aim of bringing young researches from the clinical field and IDIVAL's laboratories to present scientific advances in their current research projects. These sessions are intended to encourage discussion and networking among the researchers and doctors and to add value to the work being carried out. Researchers […]
La Vanguardia El Diario Montañés El Norte de Castilla El Digital de Asturias Salamanca 24 Horas
T lymphocytes are blood cells whose mission is to destroy the malignant cells that affect our organism. They fight against diseased cells that sometimes originate in organs or those that have been infected by viruses. However, when they undergo certain genetic alterations they can cause tumors such as peripheral T-cell lymphomas, which have a very […]
